Clinical trial
A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance in STEMI Patients (Flash IV)
NCT06118450 is registered in ClinicalTrials.gov with The Affiliated Hospital of Xuzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance in STEMI Patients (Flash IV)
- Lead sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 1, 2023
- Completion date
- May 31, 2025
- Enrollment
- 335 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
microvascular coronary artery disease, stemi